Dr. Hanna Engler
Beta-amyloid, tau- and phospho-tau protein as CSF biomarkers for differentiation of early Alzheimer's dementia, non-Alzheimer dementias and normal controls
Engler H, Soppelsa F, Felbecker A, Torzewski M (2011). Beta-amyloid, tau- and phospho-tau protein as CSF biomarkers for differentiation of early Alzheimer's dementia, non-Alzheimer dementias and normal controls.
02.11.2011Beta-amyloid, tau- and phospho-tau protein as CSF biomarkers for differentiation of early Alzheimer's dementia, non-Alzheimer dementias and normal controls
02.11.2011Annual Assembly of the SSCC & Tri-National Congress of Laboratory Medicine
Engler Hanna, Soppelsa F, Felbecker Ansgar, Torzewski Michael
Changes in biochemical markers after lower limb fractures
Stoffel K, Engler H, Kuster M, Riesen W. Changes in biochemical markers after lower limb fractures. Clinical chemistry 2007; 53:131-4.
01.01.2007Changes in biochemical markers after lower limb fractures
01.01.2007Clinical chemistry 2007; 53:131-4
Stoffel Karl, Engler Hanna, Kuster Markus, Riesen Walter
Lethargy in a newborn: lithium toxicity or lab error?
Malzacher A, Engler H, Drack G, Kind C. Lethargy in a newborn: lithium toxicity or lab error?. Journal of perinatal medicine 2003; 31:340-2.
01.01.2003Lethargy in a newborn: lithium toxicity or lab error?
01.01.2003Journal of perinatal medicine 2003; 31:340-2
Malzacher Andreas, Engler Hanna, Drack Gero, Kind Christian